dbo:abstract
|
- TS/A is a mouse mammary adenocarcinoma cell line established in the early 1980s from a spontaneous tumor of a retired breeder BALB/c female mouse.In the 1990s it was widely used as a recipient cell line for the transduction of cytokine genes and other genes of immunological interest, to produce recombinant experimental vaccines that induced anti-tumor immunological responses. (en)
- TS/A是一種具有中等細胞分化能力的小鼠乳腺癌細胞系,最初在1983年分離自一隻二十個月大的雌性BALB/c小鼠的自發性腫瘤。在1990年代,它被廣泛用作轉導細胞因子基因及其他具有免疫學意義的基因的受體細胞系,以生產誘導着抗腫瘤免疫反應的重組實驗疫苗。因為具有異質性、低免疫原性及低轉移能力的特性而使其適合作為臨床前模型,並且可以應用於研究腫瘤-宿主相互作用和基因治療方法等。 (zh)
|
dbo:wikiPageExternalLink
| |
dbo:wikiPageID
| |
dbo:wikiPageLength
|
- 1662 (xsd:nonNegativeInteger)
|
dbo:wikiPageRevisionID
| |
dbo:wikiPageWikiLink
| |
dbp:wikiPageUsesTemplate
| |
dcterms:subject
| |
rdfs:comment
|
- TS/A is a mouse mammary adenocarcinoma cell line established in the early 1980s from a spontaneous tumor of a retired breeder BALB/c female mouse.In the 1990s it was widely used as a recipient cell line for the transduction of cytokine genes and other genes of immunological interest, to produce recombinant experimental vaccines that induced anti-tumor immunological responses. (en)
- TS/A是一種具有中等細胞分化能力的小鼠乳腺癌細胞系,最初在1983年分離自一隻二十個月大的雌性BALB/c小鼠的自發性腫瘤。在1990年代,它被廣泛用作轉導細胞因子基因及其他具有免疫學意義的基因的受體細胞系,以生產誘導着抗腫瘤免疫反應的重組實驗疫苗。因為具有異質性、低免疫原性及低轉移能力的特性而使其適合作為臨床前模型,並且可以應用於研究腫瘤-宿主相互作用和基因治療方法等。 (zh)
|
rdfs:label
| |
owl:sameAs
| |
prov:wasDerivedFrom
| |
foaf:isPrimaryTopicOf
| |
is dbo:wikiPageDisambiguates
of | |
is dbo:wikiPageWikiLink
of | |
is foaf:primaryTopic
of | |